Winter storm warning: The National Weather Service has posted a Winter Storm Warning for parts of the state Wednesday morning through Thursday morning.  Stay with WTIC NewsTalk 1080 for the latest forecast, and for traffic problems resulting from the weather. Read More

Local News

Pfizer Earnings Down From Last Year, Still Exceed Expectations

View Comments
Pfizer (Timothy A. Clary/Getty Images)

Pfizer (Timothy A. Clary/Getty Images)

NEW YORK (AP) _ Pfizer’s second-quarter earnings plunged 79 percent from last year, when the world’s second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.

The New York company said Tuesday it earned $2.91 billion, or 45 cents per share, in the quarter. That compares with earnings of $14.1 billion, or $1.98 per share, last year. Adjusted earnings totaled 58 cents per share.

Analysts expected, on average, earnings of 57 cents per share, according to FactSet.

Revenue slipped 2 percent to $12.77 billion, while analysts forecast $12.47 billion, on average.

Pfizer Inc. is best known for creating medicines for the masses, including the erectile dysfunction pill Viagra, the Prevnar vaccine against pneumonia and related infections, and the now-generic cholesterol fighter Lipitor, which was once the world’s best-selling drug.

Over the last three years, Pfizer has divested assets outside its core business. It sold its capsule-making operation and its nutrition business for a total of nearly $14 billion. Then it spun off its animal health business as a new company in June 2013.

That’s when it divested its remaining 80 percent stake in the new company, called Zoetis Inc., receiving an after-tax gain of $10.6 billion.

(© Copyright 2014 The Associated Press. All Rights Reserved.)

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 882 other followers